Kim I Y, Veres Z, Stadtman T C
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1992 Sep 25;267(27):19650-4.
Synthesis of a labile selenium donor compound, selenophosphate, from selenide and ATP by the Escherichia coli SELD enzyme was reported previously from this laboratory. From the gene sequence, SELD is a 37-kDa protein that contains 7 cysteine residues, 2 of which are located at positions 17 and 19 in the sequence -Gly-Ala-Cys-Gly-Cys-Lys-Ile- (Leinfelder, W., Forchhammer, K., Veprek, B., Zehelein, E., and Böck, A. (1990) Proc. Natl. Acad. Sci. U.S.A. 73, 543-547). Inactivation of the enzyme by alkylation with iodoacetamide indicated that at least 1 cysteine residue in the protein is essential for enzyme activity. To test the possibility that the Cys17 and/or Cys19 residue might be essential, these were changed to serine residues by site-specific mutagenesis. The biological activities of the wild type and mutant proteins were studied using E. coli MB08 (selD-) transformed with plasmids containing the selD genes. The plasmid containing the Cys17-mutated gene failed to complement MB08, whereas the Cys19-mutated gene was indistinguishable from wild type. The mutant proteins, like the wild type enzyme, bound to an ATP-agarose matrix, showing that their affinities for ATP were unimpaired. Selenide-dependent formation of AMP from ATP was abolished by mutation of Cys17, but the Cys19 mutation had no effect on the ability of the enzyme to catalyze the reaction. These results indicate that Cys17 has an essential role in the catalytic process that leads to the formation of selenophosphate from ATP and selenide.
本实验室先前报道了大肠杆菌SELD酶利用硒化物和ATP合成不稳定的硒供体化合物硒磷酸酯的过程。从基因序列来看,SELD是一种37 kDa的蛋白质,含有7个半胱氨酸残基,其中2个位于序列-Gly-Ala-Cys-Gly-Cys-Lys-Ile-的第17和19位(莱因费尔德,W.,福克哈默,K.,韦普雷克,B.,泽赫林,E.,和博克,A.(1990年)《美国国家科学院院刊》73,543 - 547)。用碘乙酰胺进行烷基化使该酶失活,这表明该蛋白质中至少有1个半胱氨酸残基对酶活性至关重要。为了测试半胱氨酸17和/或半胱氨酸19残基可能至关重要的可能性,通过定点诱变将它们替换为丝氨酸残基。使用含有selD基因的质粒转化的大肠杆菌MB08(selD-)研究了野生型和突变型蛋白质的生物学活性。含有半胱氨酸17突变基因的质粒未能使MB08得到互补,而半胱氨酸19突变基因与野生型没有区别。与野生型酶一样,突变型蛋白质与ATP - 琼脂糖基质结合,表明它们对ATP的亲和力未受损害。半胱氨酸17的突变消除了ATP依赖于硒化物形成AMP的过程,但半胱氨酸19的突变对该酶催化反应能力没有影响。这些结果表明,半胱氨酸17在由ATP和硒化物形成硒磷酸酯的催化过程中起关键作用。